These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dopamine-norepinephrine interaction in hyperactive boys treated with d-amphetamine. Shekim WO, Dekirmenjian H, Javaid J, Bylund DB, Davis JM. J Pediatr; 1982 May; 100(5):830-4. PubMed ID: 7069551 [Abstract] [Full Text] [Related]
3. Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine. Shekim WO, Dekirmenjian H, Chapel JL. Am J Psychiatry; 1977 Nov; 134(11):1276-9. PubMed ID: 910984 [Abstract] [Full Text] [Related]
4. Norepinephrine metabolism and clinical response to dextroamphetamine in hyperactive boys. Shekim WO, Dekirmenjian H, Chapel JL, Javaid J, Davis JM. J Pediatr; 1979 Sep; 95(3):389-94. PubMed ID: 469661 [Abstract] [Full Text] [Related]
5. Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys. Shekim WO, Javaid J, Dekirmenjian H, Chapel JL, Davis JM. Am J Psychiatry; 1982 Apr; 139(4):485-8. PubMed ID: 7065295 [Abstract] [Full Text] [Related]
6. Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine. Shekim WO, Dekirmenjian H, Chapel JL. Am J Psychiatry; 1979 May; 136(5):667-71. PubMed ID: 434244 [Abstract] [Full Text] [Related]
7. Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine. Shekim WO, Javaid J, Davis JM, Bylund DB. Biol Psychiatry; 1983 Jun; 18(6):707-14. PubMed ID: 6871304 [Abstract] [Full Text] [Related]
8. Urinary free and conjugated catecholamines and metabolites in autistic children. Barthelemy C, Bruneau N, Cottet-Eymard JM, Domenech-Jouve J, Garreau B, Lelord G, Muh JP, Peyrin L. J Autism Dev Disord; 1988 Dec; 18(4):583-91. PubMed ID: 3215884 [Abstract] [Full Text] [Related]
11. The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication. Zametkin AJ, Hamburger SD. Biol Psychiatry; 1988 Feb 15; 23(4):350-6. PubMed ID: 3342265 [Abstract] [Full Text] [Related]
12. Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans. Alonso R, Gibson CJ, Wurtman RJ, Agharanya JC, Prieto L. Biol Psychiatry; 1982 Jul 15; 17(7):781-90. PubMed ID: 7115832 [Abstract] [Full Text] [Related]
13. [Catecholamines and their metabolites in children with Asperger and Kanner syndromes]. Gorina AS, Kolesnichenko LS, Mikhnovich VI. Biomed Khim; 2011 Jul 15; 57(5):562-70. PubMed ID: 22629607 [Abstract] [Full Text] [Related]
17. Treatment of hyperactive children with monoamine oxidase inhibitors. II. Plasma and urinary monoamine findings after treatment. Zametkin A, Rapoport JL, Murphy DL, Linnoila M, Karoum F, Potter WZ, Ismond D. Arch Gen Psychiatry; 1985 Oct 15; 42(10):969-73. PubMed ID: 2412521 [Abstract] [Full Text] [Related]
18. Urinary 3-methyoxy-4-hydroxyphenylglycol and homovanillic acid response to d-amphetamine in hyperactive children. Brown GL, Ebert MH, Hunt RD, Rapoport JL. Biol Psychiatry; 1981 Aug 15; 16(8):779-87. PubMed ID: 7197170 [No Abstract] [Full Text] [Related]
19. [Increase of excretion of urinary catecholamines and its catabolites in a case of pulmonary sarcomatous tumor]. Candito M, Bekri S, Monpoux P, Parisot F, Mariani R, Chambon P. Pathol Biol (Paris); 1992 Dec 15; 40(10):1003-5. PubMed ID: 1299807 [Abstract] [Full Text] [Related]